Advertisement

Topics

Pfenex Inc. Company Profile

01:48 EST 19th November 2017 | BioPortfolio

Pfenex is a protein production company leveraging the unique and powerful Pfenex Expression Technology(TM) platform based on the micro-organism, Pseudomonas fluorescens, for the production of research proteins, reagent proteins, biosimilars and innovator biopharmaceuticals. For more information please visit www.pfenex.com


News Articles [27 Associated News Articles listed on BioPortfolio]

Pfenex Inc. to Present at the Jefferies 2017 London Healthcare Conference

Pfenex investors and others should note that we announce material information to the public about the Company through a variety of means, including our website Read more...

Pfenex names Eef Schimmelpennink as CEO

US clinical-stage biotech firm Pfenex today announced the appointment of Evert (Eef) Schimmelpennink…

Pfenex To Present at the 19th Annual Rodman and Renshaw Global Investment Conference on ...

Pfenex investors and others should note that we announce material information to the public about the Company through a variety of means, including our website Read more...

Pfenex to Report Third Quarter 2017 Results and Provide Business Update on Thursday, November ...

Please call 1-866-376-8058 (US) or 1-412-317-6011 (international) and reference Pfenex to access the call. A replay of the conference call will be available approximately one hour Read more...

Pfenex Announces Management Changes

SAN DIEGO, Sept. 7, 2017 /PRNewswire/ -- Pfenex Inc. (NYSE MKT: PFNX), today announced that Dr. Paul Wagner, Chief Financial Officer, is leaving the Company effective October 13, 2017 to assume a...

Pfenex To Present at the 6th Annual Liolios Gateway Conference on September 6th, 2017

SAN DIEGO, Aug. 23, 2017 /PRNewswire/ -- Pfenex Inc. (NYSE MKT: PFNX) announced today that it will be presenting at the 6th Annual Liolios Gateway Conference on September 6th, 2017 at 11:00 am PT...

Pfenex To Present at the 19th Annual Rodman and Renshaw Global Investment Conference on September 12th, 2017

SAN DIEGO, Aug. 29, 2017 /PRNewswire/ -- Pfenex Inc. (NYSE MKT: PFNX) announced today that it will be presenting at the 19th Annual Rodman and Renshaw Global Investment Conference on September 12th, 2...

Pfenex To Present at the Cantor Fitzgerald Global Healthcare Conference on September 27th, 2017

SAN DIEGO, Sept. 19, 2017 /PRNewswire/ -- Pfenex Inc. (NYSE MKT: PFNX) announced today that it will be presenting at the Cantor Fitzgerald Global Healthcare Conference on September 27th, 2017 at ...

Drugs and Medications [0 Results]

None

PubMed Articles [0 Results]

None

Clinical Trials [0 Results]

None

Companies [1 Associated Companies listed on BioPortfolio]

Pfenex Inc.

Pfenex is a protein production company leveraging the unique and powerful Pfenex Expression Technology(TM) platform based on the micro-organism, Pseudomonas fluorescens, for the production of research...

More Information about "Pfenex Inc." on BioPortfolio

We have published hundreds of Pfenex Inc. news stories on BioPortfolio along with dozens of Pfenex Inc. Clinical Trials and PubMed Articles about Pfenex Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Pfenex Inc. Companies in our database. You can also find out about relevant Pfenex Inc. Drugs and Medications on this site too.

Quick Search
Advertisement
 

Relevant Topic

Nutrition
Within medicine, nutrition (the study of food and the effect of its components on the body) has many different roles. Appropriate nutrition can help prevent certain diseases, or treat others. In critically ill patients, artificial feeding by tubes need t...


Corporate Database Quicklinks



Searches Linking to this Company Record